Beauty Health Income from Discontinued Operations 2020-2025 | SKIN
Beauty Health income from discontinued operations from 2020 to 2025. Income from discontinued operations can be defined as income or loss from the complete discontinuation of a segment or business, net of associated taxes and fees.
| Beauty Health Annual Income from Discontinued Operations (Millions of US $) |
|
|---|---|
| 2024 | $0 |
| 2023 | $0 |
| 2022 | $0 |
| 2021 | $0 |
| 2020 | $0 |
| 2019 | $0 |
| Beauty Health Quarterly Income from Discontinued Operations (Millions of US $) |
|
|---|---|
| 2025-03-31 | |
| 2024-12-31 | |
| 2024-09-30 | |
| 2024-06-30 | |
| 2024-03-31 | |
| 2023-12-31 | |
| 2023-09-30 | |
| 2023-06-30 | |
| 2023-03-31 | |
| 2022-12-31 | |
| 2022-09-30 | |
| 2022-06-30 | |
| 2022-03-31 | |
| 2021-12-31 | |
| 2021-09-30 | |
| 2021-06-30 | |
| 2021-03-31 | |
| 2020-12-31 | |
| 2020-09-30 | |
| 2020-06-30 | |
| 2019-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.209B | $0.334B |
| The Beauty Health Company is a beauty health company. Its flagship brand HydraFacial is a non-invasive and approachable beauty health platform and ecosystem with a powerful community of estheticians, consumers and partners, bridging medical and consumer retail to democratize and personalize skin care solutions for the masses. The Beauty Health Company, formerly known as Vesper Healthcare Acquisition Corp., is based in CHICAGO, Utah. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $134.596B | 25.24 |
| CVS Health (CVS) | United States | $77.976B | 9.69 |
| Elevance Health (ELV) | United States | $62.251B | 8.37 |
| Cencora (COR) | United States | $56.726B | 19.74 |
| DiDi Global (DIDIY) | China | $26.168B | 27.80 |
| Labcorp Holdings (LH) | United States | $20.342B | 16.50 |
| Natera (NTRA) | United States | $19.203B | 0.00 |
| BioMerieux (BMXMF) | France | $16.276B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.895B | 0.00 |
| CochLear (CHEOY) | Australia | $13.050B | 0.00 |
| Solventum (SOLV) | United States | $12.516B | 13.25 |
| ICON (ICLR) | Ireland | $11.276B | 10.48 |
| Revvity (RVTY) | United States | $10.693B | 18.40 |
| Viatris (VTRS) | United States | $10.446B | 3.59 |
| Medpace Holdings (MEDP) | United States | $8.878B | 22.97 |
| Sonic Healthcare (SKHHY) | Australia | $8.792B | 0.00 |
| Avantor (AVTR) | United States | $8.409B | 12.22 |
| HealthEquity (HQY) | United States | $8.395B | 36.77 |
| Charles River Laboratories (CRL) | United States | $7.357B | 14.42 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.197B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.928B | 29.02 |
| BrightSpring Health Services (BTSG) | United States | $3.465B | 31.79 |
| Sotera Health (SHC) | United States | $3.125B | 17.76 |
| Surgery Partners (SGRY) | United States | $2.866B | 37.27 |
| Concentras Parent (CON) | United States | $2.557B | 14.78 |
| Alignment Healthcare (ALHC) | United States | $2.473B | 0.00 |
| Organon (OGN) | United States | $2.457B | 2.61 |
| GeneDx Holdings (WGS) | United States | $2.235B | 86.09 |
| Progyny (PGNY) | United States | $1.966B | 43.28 |
| PACS (PACS) | United States | $1.771B | 0.00 |
| Premier (PINC) | United States | $1.723B | 13.08 |
| GoodRx Holdings (GDRX) | United States | $1.697B | 33.93 |
| Ardent Health (ARDT) | United States | $1.566B | 6.68 |
| Teladoc Health (TDOC) | United States | $1.461B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.232B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.086B | 8.26 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
| Agilon Health (AGL) | United States | $0.886B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.846B | 290.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.711B | 6.66 |
| CareDx (CDNA) | United States | $0.710B | 11.09 |
| Nutex Health (NUTX) | United States | $0.618B | 9.35 |
| Embecta (EMBC) | United States | $0.601B | 4.05 |
| So-Young (SY) | China | $0.581B | 0.00 |
| SBC Medicals (SBC) | United States | $0.541B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.513B | 0.00 |
| LifeMD (LFMD) | United States | $0.474B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.470B | 10.58 |
| Sonida Senior Living (SNDA) | United States | $0.468B | 0.00 |
| Omada Health (OMDA) | $0.466B | 0.00 | |
| COMPASS Pathways (CMPS) | United Kingdom | $0.417B | 0.00 |
| Enhabit (EHAB) | United States | $0.340B | 28.00 |
| Oncology Institute (TOI) | United States | $0.304B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.295B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.149B | 0.00 |
| DocGo (DCGO) | United States | $0.145B | 23.67 |
| Sera Prognostics (SERA) | United States | $0.110B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.081B | 0.00 |
| KindlyMD (NAKA) | United States | $0.066B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.060B | 0.00 |
| Biodesix (BDSX) | United States | $0.051B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.045B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.043B | 0.00 |
| ModivCare (MODV) | United States | $0.042B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.021B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.014B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.010B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.009B | 0.00 | |
| SeaStar Medical Holding (ICU) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.007B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |